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Influenza A virus NS1 protein has developed two main IFN-antagonizing mechanisms by inhibiting retinoic-acid-inducible 
gene I (RIG-I) signal transduction, or by suppressing cellular pre-mRNA processing through binding to cleavage and polyad-
enylation specific factor 30 (CPSF30). However, the precise effects of NS1 on suppressing type I IFN induction have not been 
well characterized. Here we report that compared with PR/8/34 NS1, which is localized partially in the cytoplasm and has 
strong IFN-antagonizing ability via specifically inhibiting IFN- promoter activity, H5N1 NS1 has strikingly different charac-
teristics. It mainly accumulates in the nucleus of transfected cells and exerts rather weak IFN-counteracting ability through 
suppression of the overall gene expression. The M101I mutation of H5N1 NS1, namely H5-M101I, fully reversed its functions. 
H5-M101I gained the ability to specifically inhibit IFN- promoter activity, translocate to the cytoplasm, and release CPSF30. 
The previously reported NES (nuclear export signal) (residues 138147) was unable to lead H5N1 NS1 to translocate. This 
suggests that other residues may serve as a potent NES. Findings indicated that together with leucine-100, methionine-101 en-
hanced the regional NES. In addition, methionine-101 was the key residue for the NS1-CPSF30 interaction. This study reveals 
the importance of methionine-101 in the influenza A virus life cycle and may provide valuable information for antiviral  
strategies. 
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Influenza A virus, which belongs to the Orthomyxoviridae 
family, is an enveloped, single-stranded RNA virus. Its ge-
nome is made up of eight negative RNA segments, among 
which, segment 8 encodes one of the two non-structural 
proteins [1–3], non-structural protein 1 (NS1). NS1 has two 
functional domains, the N-terminal 73-amino-acid RNA- 
binding domain (RBD) and the C-terminal effector domain 
(ED) [4]. As a viral encoded virulence factor [57], NS1 
protein has developed two main IFN-antagonizing mecha-
nisms. It sequesters dsRNA [810] generated during virus 
infection and inhibits TRIM25-mediated activation of RIG-I 
[11,12], thereby blocking the type I interferon signaling 
pathway. In addition, certain NS1 proteins have evolved 
another way to bind to cleavage and polyadenylation spe-
cific factor 30 (CPSF30) [13,14], a subunit of CPSF [15] 
and an essential component of the 3′ end processing ma-
chinery of cellular pre-mRNAs [15–17], hence, inhibiting 
cellular pre-mRNA processing, including IFN-β pre-mRNA 
[14,18].  
In 1998, a latent nuclear export signal (NES) of NS1 
protein was determined. This NES is localized in the 
N-terminus of the ED (residues 138 to 147), and is only 
present in transfected but not virus-infected cells. NS1 pro-
tein accumulates in the nucleus since the nuclear exporting 
function is inhibited by the adjacent amino acid sequence 
[19].  
934 Meng J, et al.   Sci China Life Sci   November (2012) Vol.55 No.11 
In the present study, we revealed dramatic differences 
between the NS1 proteins from PR/8/34 and H5N1 in both 
IFN-antagonizing ability and subcellular localization pat-
terns. NS1 from PR/8/34 does not bind to CPSF30 as indi-
cated by others [20–23]. Furthermore, in our study, H5N1 
NS1 was localized in the nucleus in transfected cells and 
had weak IFN-counteracting ability via binding to CPSF30. 
By construction of a series of mutants and chimeras based 
on H5N1 NS1, we found that a single amino acid substitu-
tion of methionine-101 with isoleucine (H5-M101I), alt-
hough not even close to the previously reported NES (resi-
dues 138 to 147), altered both the subcellular distribution 
pattern as well as the IFN-antagonizing ability. 
As H5N1 infection is a zoonotic disease, the predominant 
pathway of human infection is still avian-to-human trans-
mission. However, the human infection is still sporadic and 
rare [24]. Our study may help in the control of human infec-
tion of H5N1. 
1  Materials and methods 
1.1  Cells and plasmids 
293T and HeLa cells were maintained in DMEM supple-
mented with 10% FBS (Invitrogen) at 37°C with 5% CO2. 
Expression constructs for NS1 under the control of chicken 
β-actin promoter (pCAGGS-NS1) were created using EcoR I 
and Xho I with an N-terminally tagged HA. Chimera 
pCAGGS-HA-5N8C was constructed to express an 
HA-NS1 fusion protein with amino acids 1-73 (RBD) from 
H5N1 NS1 and 74-230 (ED) from influenza A/PR/8/34 
(PR8). Chimera pCAGGS-HA-8N5C was constructed to 
express RBD from PR/8/34 and ED from H5N1 NS1. The 
last 17 residues from the C-terminus of H5N1 NS1 were 
substituted for the corresponding amino acids from PR/8/34 
NS1 to construct H5-C17. H5-F98S and H5-M101I were 
created with a F98S and a M101I single mutation, respec-
tively. H5-98/101 was a mutant based on H5N1 NS1 with 
F98SM101I double mutations. H5-98-113 contains 
F98SM101IS109PK113R quadruple mutations. TMASV, 
five residues from PR/8/34 NS1 80-84aa, were added to the 
corresponding sites of the H5N1 NS1 to generate 
H5-TMASV. H5-TM-98-113 was created by overlapping 
PCR using H5-TMASV as a template. Position 70 was 
changed from E to K by overlapping PCR to generate 
H5-E70K-TMASV. Human CPSF30 was cloned into 
pCAGGS by Sma I and Xho I using the human cDNA clone 
CMV6-CPSF30 (Origene) as a template. Reporter plasmid 
p125-Luc (IFN-β-Luc) was described previously [25]. 
pRL-TK was purchased from Promega and pEF-flag-RIG-I 
was kindly provided by Dr. T. Fujita. 
1.2  Reporter gene assays 
For activation of the IFN-β promoter, 293T cells in 24-well 
plates were co-transfected with 25 ng internal control plas-
mid pRL-TK, 125 ng reporter plasmid p125-Luc, and 500 
ng of the indicated NS1 expression plasmids or 500 ng 
empty vector pCAGGS using the Calcium Phosphate-  
mediated transfection method of the Mammalian Transfec-
tion kit (Promega). Twenty-four hours post-transfection, 
cells were mock infected or infected with SeV for 16 h. 
Cells were lysed by 1× Passive Lysis Buffer at room   
temperature for 15 min. Luciferase activities were deter-
mined using the Dual-Luciferase Reporter Assay System 
(Promega). 
1.3  Western blot analysis 
Cells were washed with PBS once and lysed by lysis buffer 
for Western and Immunoprecipitation (Beyotime) in the 
presence of Protease Inhibitor Cocktail (Roche). Proteins 
were separated by 10% SDS-PAGE and transferred onto 
polyvinylidenedifluoride (PVDF) membranes (Millipore). 
NS1 proteins were detected by polyclonal rabbit anti-NS1 
or rabbit anti-HA (Ab-mart). Monoclonal anti-β-actin anti-
body was purchased from Beyotime and Monoclonal anti-
body against Flag was purchased from Sigma. 
1.4  Immunofluorescence and confocal microscopy 
To detect the subcellular location of NS1, HeLa cells grown 
on glass slides were transfected with NS1-expression plas-
mids. Twenty-four hours post-transfection, cells were fixed 
with 4% paraformaldehyde for 15 min and then permea-
bilized with 0.1% Triton-X 100 for another 15 min at RT, 
followed by blocking with 5% BSA overnight at 4°C. After 
washing once with PBS, the cells were incubated with an-
ti-HA antibody (Sigma-Aldrich) at 4°C overnight. Cells 
were then washed three times, and incubated for 40 min 
with the secondary antibody, either fluorescein isothiocya-
nate-conjugated (FITC) or rhodamine-conjugated antibody 
(Pierce). After four washes with PBS, cells were stained 
with Hoechst 33258 (Beyotime). Cells were incubated at 
room temperature for 10 min, washed three times for 5 min 
each, and examined by TCS SP2 laser scanning confocal 
microscope (Leica, Wetzlar, Germany). 
1.5  Coimmunoprecipitation (CoIP) 
293T cells in 6-well plates were transfected with 2 μg NS1 
expression plasmids or pCAGGS and 2 g pCAGGS- 
CPSF30-flag separately. Twenty-four hours post-transfec- 
tion, cells were washed with cold PBS once, lysed in lysis 
buffer, and clarified by centrifugation at 16000×g for 5 min 
at 4°C. CoIP assays were performed using Dynabeads Pro-
tein G Immunoprecipitation Kit (Invitrogen) according to 
manufacturer’s recommendations. Briefly, 10 μg anti-Flag 
mAb M2 (Sigma) or nonspecific mouse IgG diluted in    
200 μL Ab Binding & Washing Buffer were incubated with 
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50 μL Dynabeads for 10 min at room temperature to allow 
formation of a Dynabeads-Ab complex. After gently wash-
ing, the beads were incubated with cell lysates for 10 min to 
allow Ag to bind to the Dynabeads-Ab complex. After rins-
ing four times, the captured Ags were eluted and subjected 
to SDS-PAGE and Western blot analysis.  
2  Results 
2.1 H5N1 NS1 protein had relatively weak IFN-     
antagonizing ability compared with that of PR/8/34 NS1 
Influenza A virus NS1 protein is a virulence factor in coun-
teracting IFN-mediated antiviral responses of the host [5–7]. 
It was previously reported that NS1 differed markedly in 
inhibiting IRF3 activation and IFN-β transcription [26]. In 
the present study, we found that unlike PR/8/34 NS1, NS1 
of H5N1 differed significantly in its ability to inhibit IFN-β 
promoter activation and affect expression of reference genes 
(Figure 1A). As reported previously, PR/8/34 NS1 could 
enhance reporter gene expression when co-transfected with 
293T cells [27]. Similarly, we found that reference gene 
(RL-TK) expression level in PR/8/34 NS1-transfected cells 
increased four times compared with that in empty vector 
(pCAGGS)-transfected cells, whilst the firefly luciferase 
(IFN-β-Luc) gene expression was reduced by around 20 
times. In terms of the H5N1 NS1 protein, RL-TK and 
IFN-β-Luc expression levels were both decreased. However, 
the former was reduced to a much greater extent, which 
resulted in a significantly higher relative luciferase activity 
compared with that of PR/8/34 NS1. We concluded that 
both PR/8/34 and H5N1 NS1 could suppress IFN-β pro-
moter activity. The former severely blocked the IFN-β sig-
naling pathway. On the other hand, the latter moderately 
blocked the IFN production by generally inhibiting host 
gene expression. Since the expression level of PR/8/34 NS1 
was significantly higher than that of H5N1 NS1, we trans-
fected 293T cells with decreasing amounts of PR/8/34 NS1 
expression plasmid in reporter gene assays to test whether 
the lower expression level was the main cause of the weak 
IFN-antagonizing ability in the case of H5N1 NS1. Figure 
2A shows that even at the same expression level, PR/8/34 
still had a much stronger ability to suppress IFN-β promoter 
activity than that of H5N1. 
2.2  The effector domain of H5N1 NS1 protein deter-
mined its IFN-antagonizing ability and subcellular dis-
tribution pattern 
Influenza A virus NS1 protein has two domains, N-terminal 
RNA-binding domain (RBD, amino acids 1–73) and 
C-terminal effector domain (ED, residue 74 to the last 
C-terminal residue). To determine which domain contrib-
utes more to counteracting IFN, two chimeras were con- 
 
Figure 1  H5N1 NS1 protein has relatively weak IFN-antagonizing ability 
compared with that of PR/8/34 NS1. A, 293T cells were transfected with 
500 ng NS1 expression plasmids or pCAGGS together with 50 ng pRL-TK 
and 250 ng p125-Luc. 24 h post-transfection, cells were left mock infected 
or infected with SeV. 16 h later, total cell lysates were collected and sub-
jected to luciferase reporter gene assays. pCAGGS transfected cells with or 
without SeV treatment were used as positive and negative controls, respec-
tively. B, The corresponding protein expression levels were analyzed by 
Western blot. Data are representative of at least two independent experi-
ments, with each determination performed in duplicate (mean±SD). *, 
P<0.05; **, P<0.01, as determined by student’s t test. Immunoblotting of  
β-actin was used to verify equal loading of protein in each lane. 
 
structed with an N-terminal-tagged HA, named pCAGGS- 
HA-5N8C (an HA-NS1 fusion protein with amino acids 
1–73 (RBD) from H5N1 NS1 and 74–230 (ED) from influ-
enza A/PR/8/34 (PR8)) and pCAGGS-HA-8N5C (RBD 
from PR/8/34 and ED from H5N1 NS1), respectively. We 
subsequently analyzed their ability to inhibit IFN-β promot-
er activity. As shown in Figure 3A, chimera 5N8C but not 
8N5C strongly suppressed the IFN-β promoter activity, 
suggesting that the ED of H5N1 NS1 might play a dominant  
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Figure 2  Even at the same expression level, PR/8/34 still possessed a 
much stronger ability to suppress IFN-β promoter activity compared with 
that of H5N1. A, 293T cells were transfected with the indicated amount of 
PR/8/34 NS1 (lanes 25), 500 ng H5N1 NS1 (lane 6) or 500 ng pCAGGS 
(lanes 1 and 7) together with 50 ng pRL-TK and 250 ng p125-Luc. 24 h 
post-transfection, cells were mock infected or infected with SeV. 16 h later, 
total cell lysates were collected and subjected to luciferase reporter gene 
assays. pCAGGS transfected cells with or without SeV treatment were 
used as positive and negative controls, respectively. B, The corresponding 
protein expression levels were analyzed by Western blot. Data are repre-
sentative of at least two independent experiments, with each determination 
performed in duplicate (mean±SD). *, P<0.05; **, P<0.01, as determined 
by student’s t test. Immunoblotting of β-actin was used to verify equal  
loading of protein in each lane. 
 
 
role in its IFN-antagonizing ability. What is more, chimera 
5N8C was similar in its ability to inhibit the reference gene 
and 125-Luc reporter gene expression. Given that PR/8/34 
NS1 is partially targeted to the cytoplasm and remarkably 
inhibited IFN-β promoter activity, we performed confocal 
microscopy assays to confirm if chimera 5N8C could trans-
locate. As shown in Figure 4, both the PR/8/34 and chimera 
5N8C NS1 proteins partially translocated to the cytoplasm. 
We hypothesize that the subcellular distribution pattern of 
NS1 protein might correlate with its IFN-counteracting ca-
pability. 
2.3  NS1 with M101I mutation translocated to the cyto-
plasm with enhanced IFN-antagonizing ability 
To further test our hypothesis above, we analyzed the NLS 
(nuclear location signal) and NES of H5N1 NS1. In influ-
enza A virus NS1 protein, NLS2 is within the ED (effector 
domain) between amino acids 203 to 237, with the basic 
residues 219, 220, 224, 229, 231 and 232 being most critical, 
and was confirmed to be still functional even though the 
strain-specific C-terminal extension (residues 231 to 237) 
was deleted [28,29]. We aligned the sequences of the 
C-terminal 31 amino acids between PR/8/34 and H5N1 NS1 
by DNAStarMegAlign program and noticed that there was a 
five-residue difference within the last 17 amino acids (data 
not shown). Therefore, the corresponding sites of H5N1 
 
Figure 3  The effector domain of H5N1 NS1 protein determines its 
IFN-antagonizing ability. A, 293T cells were transfected with 500 ng NS1 
expression plasmids (PR/8/34, H5N1, chimera 5N8C containing H5N1 
RBD and PR/8/34 ED, chimera 8N5C containing PR/8/34 RBD and H5N1 
ED, or pCAGGS together with 50 ng pRL-TK and 250 ng p125-Luc. 24 h 
post-transfection, cells were mock infected or infected with SeV. 16 h later, 
cell lysates were subjected to luciferase reporter gene assays. pCAGGS 
transfected cells with or without SeV treatment were used as positive and 
negative controls, respectively. B, The corresponding protein expression 
levels were analyzed by Western blot. Data are representative of at least 
two independent experiments, with each determination performed in du-
plicate (mean±SD). *, P<0.05; **, P<0.01, as determined by student’s t 
test. Immunoblotting of β-actin was used to verify equal loading of protein  
in each lane. 
 
were substituted with those from PR/8/34 to create H5-C17. 
Reporter gene assays showed 23 fold enhancement in the 
ability of H5-C17 to inhibit IFN-β promoter activity (data 
not shown). We further analyzed its subcellular distribution 
pattern by immunofluorescence and from 12 to 48 h 
post-transfection, no detectable cytoplasmic NS1 was 
observed (data not shown). By predicting NES of H5N1 
NS1 using NetNES 1.1 (http://www.cbs.dtu.dk/services/ 
NetNES), we noticed that the single mutation E70K plus  
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Figure 4  The effector domain of H5N1 NS1 protein determines its sub-
cellular distribution pattern. HeLa cells were transfected with 700 ng NS1 
expression plasmids (PR/8/34, H5N1, 5N8C and 8N5C). 24 h post-   
transfection, cells were fixed and analyzed by immunofluorescence using  
monoclonal antibody against HA tag. 
addition of TMASV to the corresponding site of H5N1 re-
stored an NES signal, which was similar to that of PR/8/34. 
However, this NES did not lead to the translocation of NS1 
12–48 h post-transfection, and did not enhance the IFN- 
antagonizing ability (data not shown). Next, we created a 
series of mutants based on H5N1 NS1 at the N-terminus of 
the effector domain (ED), from residue 79 to 113. We found 
that the M101I single mutation (H5-M101I) was sufficient 
to render the ability of NS1 to translocate from the nucleus 
to the cytoplasm (Figure 5). H5-M101I, as expected, also 
enhanced reference gene expression greatly and dramati-
cally inhibited IFN-β promoter activity specifically (Figure 
6A). These data suggest that methonine-101 of H5N1 NS1 
protein determines both the intracellular localization pattern, 
IFN-antagonizing capacity and probably even the mecha-
nism. 
2.4  H5-M101I weakly interacted with CPSF30 
Methionine 101 from H5N1 NS1 is one of two residues that 
play an important role in stabilizing the CPSF30-NS1 com-
plex [20–23,25]. We proposed that the 101 mutant might 
lose the ability to interact with CPSF30. To test this hy-
pothesis, coimmunoprecipitation (CoIP) was performed 
(Figure 7). Previous studies indicated that PR/8/34 NS1 had 
little or no binding ability to CPSF30 [20–22,25]. As shown 
in Figure 7, there was also no detectable binding between 
PR/8/34 NS1 and CPSF30. In addition, H5-M101I signifi-
cantly lost its ability to interact with CPSF30. 
 
Figure 5  H5-M101I single mutation is sufficient to render the ability of 
NS1 protein to translocate to the cytoplasm. HeLa cells were transfected 
with the indicated NS1 expression plasmids. 24 h post-transfection, cells 
were fixed and subjected to immunofluorescence assays using monoclonal 
antibodies against HA.H5-98/101, H5N1 NS1 with F98SM101I double 
mutations. H5-F98S, H5N1 NS1 with F98S single mutation. H5-M101I, 
H5N1 NS1 with M101I single mutation. H5-98-113, H5N1 NS1 with 
F98SM101I S109PK113R quadruple mutations. H5-TMASV-103-118, 
residues 80 to 84 (TMASV) from PR/8/34 NS1 were added to the corre-
sponding sites of H5-98-113. Data are representative of at least two inde- 
pendent experiments. 
3  Discussion 
In the present study, we further confirmed that one amino 
acid residue, methionine-101, which is outside the previ-
ously reported NES of influenza A virus NS1 protein [19,30] 
is actively involved in the subcellular distribution process of 
NS1. Compared with the wild type protein, H5N1 with me- 
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Figure 6  H5-M101I increased its ability in inhibiting IFN-β promoter 
activity. A, 293T cells were transfected with 500 ng of the NS1 expression 
plasmids or pCAGGS together with 50 ng pRL-TK and 250 ng p125-Luc. 
24 h post-transfection, cells were mock infected or infected with SeV. 16 h 
later, cell lysates were collected and subjected to luciferase reporter gene 
assays. pCAGGS transfected cells with or without SeV treatment were 
used as positive and negative controls, respectively. B, The corresponding 
protein expression levels were analyzed by Western blot. Data are repre-
sentative of at least two independent experiments, with each determination 
performed in duplicate (mean±SD). *, P<0.05; **, P<0.01, as determined 
by student’s t test. Immunoblotting of β-actin was used to verify equal  
loading of protein in each lane. 
thionine-101 replaced by isoleucine (H5-M101I) yielded NS1 
with a much stronger IFN-antagonizing ability, a change in 
intracellular distribution, and a different target protein reser-
voir in the type I IFN signaling pathway. Our findings sug-
gest that by targeting different regions within the cell, NS1 
possesses distinct IFN-antagonizing capabilities. 
 
Figure 7  H5-M101I substantially lost the ability to interact with CPSF30. 
293T cells were transfected with 2 μg CPSF30 or 2 μg of the indicated 
NS1 expression plasmids, separately. 24 h later, cell lysates were subjected 
to coimmunoprecipitation (CoIP) assays. Mouse IgG was used as a nega- 
tive control. 
 
NES is a short amino acid sequence with several critical 
hydrophobic residues, normally leucines, which are usually 
spaced, among one another, by a couple of other amino ac-
ids [31,32]. It has been reported that isoleucine, another 
hydrophobic residue, is also critical for the function of NES 
[33,34]. In H5N1 NS1, there is a leucine (L-100) to the left 
of methionine-101, implicating that after methionine was 
substituted by isoleucine (H5-M101I), these two adjacent 
hydrophobic residues together enhanced the regional nucle-
ar export signal.  
Methionine-101 is one of two residues that function to 
stabilize the CPSF30-NS1 complex [2023,25]. Consistent 
with previous reports, the H5-M101I mutant dramatically 
reduced the ability of NS1 to bind to CPSF30. Recently, 
another group also revealed that residues responsible for the 
interaction between NS1 and CPSF30 were related to the 
localization of NS1 protein in transfected cells [35]. While 
beyond the scope of this study, it raises an interesting ques-
tion as to whether the release of CPSF30 is the direct cause 
of H5-M101I translocation. Based on our findings, it is rea-
sonable to assume that H5-M101I likely gains the ability to 
interact or dissociate with other cellular proteins which, in 
turn, may fundamentally change the IFN-antagonizing 
mechanisms.  
The formation of the H5N1-NS1-CPSF30 complex in-
hibits pre-mRNA processing which affects subsequent pro-
tein synthesis in transfected cells. This inhibition was con-
firmed by the significantly lower Renilla luciferase activity 
observed in reporter gene assays. Although the firefly lucif-
erase (125-Luc) activity was reduced significantly, it was 
not to the same extent as Renilla luciferase. There might be 
a possibility that the remaining CPSF30, which was un-
bound to H5N1 NS1, tended to show relatively higher affin-
ity to IFN-β than other promoter sequences. Therefore, 
some mature IFN-β mRNA could still be produced.  
Methionine-101 (or 106 for certain NS1) is responsible 
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for the growth and virulence of influenza A viruses. In re-
cent years, more and more influenza A viruses isolated from 
humans and avian species have NS1 which encodes methi-
onine at position 101 or 106 [22]. These revealed the crucial 
role that methionine-101/106 plays in the virus-host battle, 
although the selective pressure and the mechanisms in-
volved in the virus being able to combat the host immune 
system remain to be clarified. Apart from the correlation of 
position 101 and IFN-counteracting ability, our results 
demonstrated this crucial residue could also influence the 
subcellular localization of NS1 protein. By targeting differ-
ent regions within the cell, NS1 might possibly recruit dif-
ferent proteins to combat the host immune system, which 
contributes to our understanding of virus-host infectivity. 
This work was supported by the National Basic Research Program of Chi-
na (Grant No. 2012CB518904). We are grateful to Dr. T. Fujita for kindly 
providing the RIG-I expression plasmid. 
1 Chen W, Calvo P A, Malide D, et al. A novel influenza a virus mito-
chondrial protein that induces cell death. Nat Med, 2001, 7: 
1306–1312 
2 Lamb R A, Krug R M. Fields Virology. Philadelphia, PA: Lippincott 
Williams& Wilkins, 2001. 1487–1532 
3 Gibbs J S, Malide D, Hornung F, et al. The influenza a virus PB1-F2 
protein targets the inner mitochondrial membrane via a predicted 
basic amphipathic helix that disrupts mitochondrial function. J Virol, 
2003, 77: 7214–7224 
4 Xia S, Monzingo A F, Robertus J D. Structure of NS1A effector do-
main from the influenza A/Udorn/72 virus. Acta Crystallogr D Biol 
Crystallogr, 2009, 65: 11–17 
5 Garcia-Sastre A, Egorov A, Matassov D, et al. Influenza a virus 
lacking the NS1 gene replicates in interferon-deficient systems. Vi-
rology, 1998, 252: 324–330 
6 Bergmann M, Garcia-Sastre A, Carnero E, et al. Influenza virus NS1 
protein counteracts PKR-mediated inhibition of replication. J Virol, 
2000, 74: 6203–6206 
7 Min J Y, Krug R M. The primary function of RNA binding by the in-
fluenza a virus NS1 protein in infected cells: Inhibiting the 2'5' oligo 
(A) synthetase/RNase L pathway. Proc Natl Acad Sci USA, 2006, 
103: 7100–7105 
8 Mibayashi M, Martinez-Sobrido L, Loo Y M, et al. Inhibition of ret-
inoic acid-inducible gene I-mediated induction of beta interferon by 
the NS1 protein of influenza A virus. J Virol, 2007, 81: 514–524 
9 Talon J, Horvath C M, Polley R, et al. Activation of interferon regu-
latory factor 3 is inhibited by the influenza A virus NS1 protein. J 
Virol, 2000, 74: 7989–7996 
10 Wang X, Li M, Zheng H, et al. Influenza A virus NS1 protein pre-
vents activation of NF-kappaB and induction of alpha/beta interferon. 
J Virol, 2000, 74: 11566–11573 
11 Gack M U, Albrecht R A, Urano T, et al. Influenza A virus NS1 tar-
gets the ubiquitin ligase TRIM25 to evade recognition by the host vi-
ral RNA sensor RIG-I. Cell Host Microbe, 2009, 5: 439–449 
12 Ludwig S, Wolff T. Influenza A virus trims the type I interferon re-
sponse. Cell Host Microbe, 2009, 5: 420–421 
13 Nemeroff M E, Barabino S M L, Li Y, et al. Influenza virus NS1 
protein interacts with the cellular 30 kDa subunit of CPSF and inhib-
its 3' end formation of cellular pre-mRNAs. Mol Cell, 1998, 1: 
991–1000 
14 Noah D L, Twu K Y, Krug R M. Cellular antiviral responses against 
influenza A virus are countered at the posttranscriptional level by the 
viral NS1A protein via its binding to a cellular protein required for  
the 3′ end processing of cellular pre-mRNAs. Virology, 2003, 307: 
386–395 
15 Jenny A, Hauri H P, Keller W. Characterization of cleavage and pol-
yadenylation specificity factor and cloning of its 100-kilodalton sub-
unit. Mol Cell Biol, 1994, 14: 8183–8190 
16 Wahle E, Ruegsegger U. 3'-end processing of pre-mRNA in eukary-
otes. FEMS Microbiol Rev, 1999, 23: 277–295 
17 Danckwardt S, Hentze M W, Kulozik A E. 3′ end mRNA processing: 
molecular mechanisms and implications for health and disease. 
EMBO J, 2008, 27: 482–498 
18 Twu K Y, Noah D L, Rao P, et al. The CPSF30 binding site on the 
NS1A protein of influenza A virus is a potential antiviral target. J 
Virol, 2006, 80: 3957–3965 
19 Li Y, Yamakita Y, Krug R M. Regulation of a nuclear export signal 
by an adjacent inhibitory sequence: the effector domain of the influ-
enza virus NS1 protein. Proc Natl Acad Sci USA, 1998, 95: 
4864–4869 
20 Das K, Ma L C, Xiao R, et al. Structural basis for suppression of a 
host antiviral response by influenza A virus. Proc Natl Acad Sci USA, 
2008, 105: 13093–13098 
21 Steidle S, Martinez-Sobrido L, Mordstein M, et al. Glycine 184 in the 
non-structural protein NS1 determines virulence of influenza A virus 
strain PR8 without affecting the host interferon response. J Virol, 
2010,  
22 Twu K Y, Kuo R L, Marklund J, et al. The H5N1 influenza virus ns 
genes selected after 1998 enhance virus replication in mammalian 
cells. J Virol, 2007, 81: 8112–8121 
23 Kuo R L, Krug R M. Influenza A virus polymerase is an integral 
component of the CPSF30-NS1A protein complex in infected cells. J 
Virol, 2009, 83: 1611–1616 
24 Xu C, Dong L, Xin L, et al. Human avian influenza A (H5N1) virus 
infection in China. Sci China Ser C-Life Sci, 2009, 52: 407–411 
25 Kochs G, Garcia-Sastre A, Martinez-Sobrido L. Multiple an-
ti-interferon actions of the influenza A virus NS1 protein. J Virol, 
2007, 81: 7011–7021 
26 Kuo R L, Zhao C, Malur M, et al. Influenza A virus strains that cir-
culate in humans differ in the ability of their NS1 proteins to block 
the activation of IRF3 and interferon-beta transcription. Virology, 
2010, 408: 146–158 
27 Salvatore M, Basler C F, Parisien J P, et al. Effects of influenza A 
virus NS1 protein on protein expression: The NS1 protein enhances 
translation and is not required for shutoff of host protein synthesis. J 
Virol, 2002, 76: 1206–1212 
28 Greenspan D, Palese P, Krystal M. Two nuclear location signals in 
the influenza virus NS1 nonstructural protein. J Virol, 1988, 62: 
3020–3026 
29 Melen K, Kinnunen L, Fagerlund R, et al. Nuclear and nucleolar tar-
geting of influenza A virus NS1 protein: striking differences between 
different virus subtypes. J Virol, 2007, 81: 5995–6006 
30 Hale B G, Randall R E, Ortin J, et al. The multifunctional NS1 pro-
tein of influenza A viruses. J Gen Virol, 2008, 89: 2359–2376 
31 Gerace L. Nuclear export signals and the fast track to the cytoplasm. 
Cell, 1995, 82: 341–344 
32 Wen W, Meinkoth J L, Tsien R Y, et al. Identification of a signal for 
rapid export of proteins from the nucleus. Cell, 1995, 82: 463–473 
33 Bogerd H P, Fridell R A, Benson R E, et al. Protein sequence re-
quirements for function of the human T-cell leukemia virus type 1 
Rex nuclear export signal delineated by a novel in vivo randomiza-
tion-selection assay. Mol Cell Biol, 1996, 16: 4207–4214 
34 Fukuda M, Gotoh I, Gotoh Y, et al. Cytoplasmic localization of mi-
togen-activated protein kinase kinase directed by its NH2-terminal, 
leucine-rich short amino acid sequence, which acts as a nuclear ex-
port signal. J Biol Chem, 1996, 271: 20024–20028 
35 Han H, Cui Z Q, Wang W, et al. New regulatory mechanisms for the 
intracellular localization and trafficking of influenza A virus NS1 
protein revealed by comparative analysis of A/PR/8/34 and 
A/Sydney/5/97. J Gen Virol, 2010, 91: 2907–2917 
 
Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction 
in any medium, provided the original author(s) and source are credited. 
